1 |
Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, Geginat J. Biology of interleukin-10. Cytokine Growth Factor Rev 2010, 21, 331-344.
DOI
|
2 |
Shipkova M, Wieland E. Surface markers of lymphocyte activation and markers of cell proliferation. Clin Chim Acta 2012, 413, 1338-1349.
DOI
|
3 |
Van Zyl JM, Basson K, Kriegler A, van der Walt BJ. Mechanisms by which clofazimine and dapsone inhibit the myeloperoxidase system: a possible correlation with their anti-inflammatory properties. Biochem Pharmacol 1991, 42, 599-608.
DOI
|
4 |
Wozel G, Blasum C. Dapsone in dermatology and beyond. Arch Dermatol Res 2014, 306, 103-124.
DOI
|
5 |
Anderson R. Enhancement by clofazimine and inhibition by dapsone of production of prostaglandin E2 by human polymorphonuclear leukocytes in vitro. Antimicrob Agents Chemother 1985, 27, 257-262.
DOI
|
6 |
Booth SA, Moody CE, Dahl MV, Herron MJ, Nelson RD. Dapsone suppresses integrin-mediated neutrophil adherence function. J Invest Dermatol 1992, 98, 135-140.
DOI
|
7 |
Joo HG, Goedegebuure PS, Sadanaga N, Nagoshi M, von Bernstorff W, Eberlein TJ. Expression and function of galectin-3, a -galactoside-binding protein in activated T lymphocytes. J Leukoc Biol 2001, 69, 555-564.
|
8 |
Chakravortty D, Hensel M. Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect 2003, 5, 621-627.
DOI
|
9 |
Coleman MD. Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention. Toxicology 2001, 162, 53-60.
DOI
|
10 |
Croft M, Duan W, Choi H, Eun SY, Madireddi S, Mehta A. TNF superfamily in inflammatory disease: translating basic insights. Trends Immunol 2012, 33, 144-152.
DOI
|
11 |
Kim MH, Byon YY, Ko EJ, Song JY, Yun YS, Shin T, Joo HG. Immunomodulatory activity of ginsan, a polysaccharide of Panax ginseng, on dendritic cells. Korean J Physiol Pharmacol 2009, 13, 169-173.
DOI
|
12 |
Kountouras J, Zavos C, Chatzopoulos D. Immunomodulatory benefits of cyclosporine A in inflammatory bowel disease. J Cell Mol Med 2004, 8, 317-328.
DOI
|
13 |
Marzio R, Mauël J, Betz-Corradin S. CD69 and regulation of the immune function. Immunopharmacol Immunotoxicol 1999, 21, 565-582.
DOI
|
14 |
Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000, 117, 1162-1172.
DOI
|
15 |
Plotnikova N, Miller JL. Dermatitis herpetiformis. Skin Therapy Lett 2013, 18, 1-3.
|
16 |
Ramos-e-Silva M, Rebello PFB. Leprosy. Recognition and treatment. Am J Clin Dermatol 2001, 2, 203-211.
DOI
|
17 |
Rincon M. Interleukin-6: from an inflammatory marker to a target for inflammatory diseases. Trends Immunol 2012, 33, 571-577.
DOI
|